Company news
OmniAb, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights
October 30, 2026
OmniAb to Participate in Upcoming Investor Conferences in November
October 26, 2026
OmniAb to Report Third Quarter 2026 Financial Results on October 30
October 14, 2026
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
October 6, 2026
OmniAb to Participate in Upcoming Investor Conferences
August 26, 2026
OmniAb Raises 2026 Financial Guidance
August 17, 2026
OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026
OmniAb to Report Second Quarter 2026 Financial Results on August 6
July 16, 2026
OmniAb Names Amechi Nwachuku Chief Operating Officer
July 13, 2026
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
May 7, 2026
OmniAb to Participate in Three Upcoming Investor Conferences
April 24, 2026
OmniAb to Report First Quarter 2026 Financial Results on May 7
April 21, 2026
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 4, 2026
OmniAb to Participate at the Leerink Partners Global Healthcare Conference
February 24, 2026
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
February 19, 2026
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
December 15, 2025
OmniAb to Hold OmniUltra Virtual Investor Event on December 15
December 4, 2025
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
November 17, 2025
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
November 4, 2025
OmniAb to Participate in Three Investor Conferences in November
October 16, 2025
OmniAb to Report Third Quarter 2025 Financial Results on November 4
October 14, 2025
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
OmniAb Announces $30 Million Private Placement
August 25, 2025
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights
August 6, 2025
OmniAb to Report Second Quarter 2025 Financial Results on August 6
July 16, 2025
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit
May 13, 2025
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
May 8, 2025
OmniAb Introduces the xPloration® Partner Access Program
May 8, 2025
OmniAb to Participate in Five Upcoming Investor Conferences
May 1, 2025
OmniAb Announces Two New Appointments to its Board of Directors
April 21, 2025
OmniAb to Report First Quarter 2025 Financial Results on May 8
April 14, 2025
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 18, 2025
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18
February 24, 2025
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights
November 11, 2024
OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights
August 7, 2024
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
June 2, 2024
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
May 8, 2024
OmniAb to Report First Quarter 2024 Financial Results on May 9
April 21, 2024
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
March 19, 2024
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
February 25, 2024
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
November 8, 2023
OmniAb Appoints Steve Love to its Board of Directors
October 31, 2023
OmniAb Announces Agenda for its Research & Technology Virtual Event
October 30, 2023
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
August 9, 2023
OmniAb Announces the Passing of Director Sunil Patel
August 6, 2023
OmniAb to Report Second Quarter 2023 Financial Results on August 10
July 30, 2023
OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo
May 16, 2023
OmniAb Reports First Quarter 2023 Financial Results and Business Highlights
May 10, 2023
OmniAb to Report First Quarter 2023 Financial Results on May 11
April 30, 2023
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 29, 2023
Calls
The 5 newest of 16 calls. Every call is listed under its year.
- Omniab (NASDAQ:OABI) Q3 2026 Earnings Call
Oct 30, 2026
Transcript - Omniab (NASDAQ:OABI) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - Omniab (NASDAQ:OABI) Q1 2026 Earnings Call
May 7, 2026
Transcript - Omniab (NASDAQ:OABI) Q4 2025 Earnings Call
Mar 4, 2026
Transcript - Omniab (NASDAQ:OABI) Q3 2025 Earnings Call
Nov 4, 2025
Transcript
Decks
The 5 newest of 40 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 27 slides · Oct 30, 2026
- Investor Day (October 2026)
Investor day · 69 slides · Oct 6, 2026
- Q2 2026 Earnings Presentation
Earnings · 24 slides · Aug 6, 2026
- Q1 2026 Earnings Presentation
Earnings · 22 slides · May 7, 2026
- Q4 2025 Earnings Presentation
Earnings · 26 slides · Mar 4, 2026